GlassScriptPhysician profile
Jade L Breeback
NPI 1922351188
$7,610.83
in general payments reported to CMS, 2019-2025
47 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,338 · 2022: $1,442 · 2023: $1,727 · 2024: $1,605 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,831.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,227.67 | 2021-2025 | |
| Novo Nordisk INC | $882.61 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $875.15 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $726.76 | 2021-2025 | |
| Abbott Laboratories | $610.78 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $459.33 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $357.50 | 2021-2024 | Otezla, Repatha, Prolia |
| Otsuka America Pharmaceutical, INC. | $199.25 | 2023-2025 | Rexulti |
| Astellas Pharma US INC | $174.90 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $146.76 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceuticals, INC. | $139.09 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $135.16 | 2022 | |
| Sanofi-Aventis U.S. LLC | $122.65 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.75 | 2021-2023 | Jardiance |
| Vanda Pharmaceuticals INC. | $108.44 | 2024-2025 | Fanapt, Hetlioz |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Breeback listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.